Physician profile
Brian Song
NPI 1083108468
$766.26
in general payments reported to CMS, 2019-2025
11 companies · $70.86 in 2025
The $70.86 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.62 · 2020: $19.26 · 2021: $83.75 · 2022: $135 · 2023: $426 · 2025: $70.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.05 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $431.41 | 2022-2023 | |
| Biohorizons Implant Systems INC. | $122.54 | 2021-2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $70.86 | 2025 | Arestin, Ossix Plus |
| Ultradent Products INC | $29.98 | 2021 | |
| Tulsa Dental Products LLC | $26.46 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.05 | 2023 | Ajovy |
| Kerr Corporation | $19.26 | 2020 | |
| Philips North America LLC | $15.47 | 2023 | |
| Gc America INC. | $11.67 | 2022 | |
| Kettenbach LP | $11.40 | 2023 | |
| Voco America INC. | $5.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.